Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36‐week, randomized, double‐blind, parallel‐group trial
Seino, Yutaka, Kaneko, Shizuka, Fukuda, Shuichi, Osonoi, Takeshi, Shiraiwa, Toshihiko, Nishijima, Keiji, Bosch‐Traberg, Heidrun, Kaku, Kohei
Published in Journal of diabetes investigation (01.07.2016)
Published in Journal of diabetes investigation (01.07.2016)
Get full text
Journal Article
Health‐related quality of life in people with type 2 diabetes participating in the LEADER trial
Nauck, Michael A., Buse, John B., Mann, Johannes F. E., Pocock, Stuart, Bosch‐Traberg, Heidrun, Frimer‐Larsen, Helle, Ye, Qing, Gray, Alastair
Published in Diabetes, obesity & metabolism (01.03.2019)
Published in Diabetes, obesity & metabolism (01.03.2019)
Get full text
Journal Article
Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population
Funch, Donnie, Mortimer, Kathleen, Ziyadeh, Najat J., Seeger, John D., Li, Ling, Norman, Heather, Major‐Pedersen, Atheline, Bosch‐Traberg, Heidrun, Gydesen, Helge, Dore, David D.
Published in Diabetes, obesity & metabolism (01.08.2019)
Published in Diabetes, obesity & metabolism (01.08.2019)
Get full text
Journal Article
Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of a phase 3 randomized clinical trial
Kaneko, Shizuka, Nishijima, Keiji, Bosch‐Traberg, Heidrun, Kaku, Kohei, Seino, Yutaka
Published in Journal of diabetes investigation (01.07.2018)
Published in Journal of diabetes investigation (01.07.2018)
Get full text
Journal Article
A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg
Seino, Yutaka, Miyoshi, Hideaki, Bosch Traberg, Heidrun, Divyalasya, T V S, Nishijima, Keiji, Terauchi, Yasuo
Published in Journal of diabetes investigation (01.08.2022)
Published in Journal of diabetes investigation (01.08.2022)
Get full text
Journal Article
Safety and efficacy of the combination of the glucagon‐like peptide‐1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post‐hoc analysis of a randomized, 52‐week, open‐label, parallel‐group trial
Kiyosue, Arihiro, Seino, Yutaka, Nishijima, Keiji, Bosch‐Traberg, Heidrun, Kaku, Kohei
Published in Journal of diabetes investigation (01.07.2018)
Published in Journal of diabetes investigation (01.07.2018)
Get full text
Journal Article
Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial
Tack, Cees J., Jacob, Stephan, Desouza, Cyrus, Bain, Stephen C., Buse, John B., Nauck, Michael A., Petrie, John R., Poulter, Neil R., Pratley, Richard E., Stegmann, Helen Vanya B. K., Bosch‐Traberg, Heidrun, Startseva, Elena, Zinman, Bernard
Published in Diabetes, obesity & metabolism (01.11.2019)
Published in Diabetes, obesity & metabolism (01.11.2019)
Get full text
Journal Article
Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52‐week, open‐label, parallel‐group trial
Kaku, Kohei, Kiyosue, Arihiro, Ono, Yuri, Shiraiwa, Toshihiko, Kaneko, Shizuka, Nishijima, Keiji, Bosch‐Traberg, Heidrun, Seino, Yutaka
Published in Journal of diabetes investigation (01.01.2016)
Published in Journal of diabetes investigation (01.01.2016)
Get full text
Journal Article
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
Nauck, Michael, Rizzo, Manfredi, Johnson, Andrew, Bosch-Traberg, Heidrun, Madsen, Jesper, Cariou, Bertrand
Published in Diabetes care (01.09.2016)
Published in Diabetes care (01.09.2016)
Get full text
Journal Article
Influence of Production Process and Scale on Quality of Polypeptide Drugs: a Case Study on GLP-1 Analogs
Staby, Arne, Steensgaard, Dorte Bjerre, Haselmann, Kim F., Marino, Jesper Søndergaard, Bartholdy, Christina, Videbæk, Nicoline, Schelde, Ole, Bosch-Traberg, Heidrun, Spang, Lotte Touborg, Asgreen, Désirée J.
Published in Pharmaceutical research (01.07.2020)
Published in Pharmaceutical research (01.07.2020)
Get full text
Journal Article
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
Rossing, Peter, Bain, Stephen C., Bosch-Traberg, Heidrun, Sokareva, Ekaterina, Heerspink, Hiddo J. L., Rasmussen, Søren, Mellbin, Linda G.
Published in Cardiovascular diabetology (24.08.2023)
Published in Cardiovascular diabetology (24.08.2023)
Get full text
Journal Article
Liraglutide and Glycaemic Outcomes in the LEADER Trial
Zinman, Bernard, Nauck, Michael A., Bosch-Traberg, Heidrun, Frimer-Larsen, Helle, Ørsted, David D., Buse, John B.
Published in Diabetes therapy (01.12.2018)
Published in Diabetes therapy (01.12.2018)
Get full text
Journal Article
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Perkovic, Vlado, Tuttle, Katherine R., Rossing, Peter, Mahaffey, Kenneth W., Mann, Johannes F.E., Bakris, George, Baeres, Florian M.M., Idorn, Thomas, Bosch-Traberg, Heidrun, Lausvig, Nanna Leonora, Pratley, Richard
Published in The New England journal of medicine (11.07.2024)
Published in The New England journal of medicine (11.07.2024)
Get full text
Journal Article
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
Rossing, Peter, Baeres, Florian M M, Bakris, George, Bosch-Traberg, Heidrun, Gislum, Mette, Gough, Stephen C L, Idorn, Thomas, Lawson, Jack, Mahaffey, Kenneth W, Mann, Johannes F E, Mersebach, Henriette, Perkovic, Vlado, Tuttle, Katherine, Pratley, Richard
Published in Nephrology, dialysis, transplantation (31.08.2023)
Published in Nephrology, dialysis, transplantation (31.08.2023)
Get full text
Journal Article
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo
Tuttle, Katherine R., Bosch-Traberg, Heidrun, Cherney, David Z.I., Hadjadj, Samy, Lawson, Jack, Mosenzon, Ofri, Rasmussen, Søren, Bain, Stephen C.
Published in Kidney international (01.04.2023)
Published in Kidney international (01.04.2023)
Get full text
Journal Article
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial
Davies, Melanie J, Bain, Stephen C, Atkin, Stephen L, Rossing, Peter, Scott, David, Shamkhalova, Minara S, Bosch-Traberg, Heidrun, Syrén, Annika, Umpierrez, Guillermo E
Published in Diabetes care (01.02.2016)
Published in Diabetes care (01.02.2016)
Get full text
Journal Article
4441 KIDNEY DISEASE OUTCOMES WITH SEMAGLUTIDE VERSUS PLACEBO ACROSS BASELINE KDIGO RISK CATEGORIES: A POST HOC ANALYSIS OF SUSTAIN 6
Tuttle, Katherine, Bain, Stephen C, Bosch-Traberg, Heidrun, Cherney, David, Rasmussen, Søren, Sokareva, Ekaterina, Khunti, Kamlesh
Published in Nephrology, dialysis, transplantation (14.06.2023)
Published in Nephrology, dialysis, transplantation (14.06.2023)
Get full text
Journal Article
The authors reply
Tuttle, Katherine R., Bosch-Traberg, Heidrun, Cherney, David Z.I., Hadjadj, Samy, Mosenzon, Ofri, Rasmussen, Søren, Bain, Stephen C.
Published in Kidney international (01.09.2023)
Published in Kidney international (01.09.2023)
Get full text
Journal Article
Semaglutide Improves eGFR Slope vs. Placebo Regardless of Baseline HbA1c and Blood Pressure in People With Type 2 Diabetes: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6: SA-PO265
Cherney, David, Bosch-Traberg, Heidrun, Hadjadj, Samy, Kuhlman, Anja B., Rasmussen, Soren, Tuttle, Katherine R., Heerspink, Hiddo J. L
Published in Journal of the American Society of Nephrology (01.11.2022)
Published in Journal of the American Society of Nephrology (01.11.2022)
Get full text
Journal Article
Joint Model of eGFR Slope: Data from LEADER in Patients with Type 2 Diabetes and High Risk of Cardiovascular Events: PO0966
Mann, Johannes F., Bosch-Traberg, Heidrun, Rasmussen, Soren, Wolthers, Benjamin, Heerspink, Hiddo J. L
Published in Journal of the American Society of Nephrology (01.10.2020)
Published in Journal of the American Society of Nephrology (01.10.2020)
Get full text
Journal Article